Gut Microbiota Changes in Patients With Major Depressive Disorder Treated With Vortioxetine

Vortioxetine hydrobromide is a common clinical medication for major depressive disorder (MDD). However, it remains unclear whether vortioxetine hydrobromide acts by affecting the structure and composition of gut microbiota. Here, we analyzed fecal samples from 28 healthy controls (HCs) and 26 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Xiaolin, Wang, Dong, Zhu, Huaqian, Wang, Dahai, Li, Jing, Tang, Yanqing, Wu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138160/
https://www.ncbi.nlm.nih.gov/pubmed/34025474
http://dx.doi.org/10.3389/fpsyt.2021.641491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138160/
https://www.ncbi.nlm.nih.gov/pubmed/34025474
http://dx.doi.org/10.3389/fpsyt.2021.641491

Ejemplares similares